Perrigo Company

The momentum for this stock is not very good. Perrigo Company has good value characteristics. Perrigo Company is not very popular among insiders. Perrigo Company is a mediocre stock to choose.
Log in to see more information.
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consume...

News

PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY

PR Newswire PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE...\n more…

Perrigo Company plc (NYSE:PRGO) Shares Bought by Victory Capital Management Inc.
Perrigo Company plc (NYSE:PRGO) Shares Bought by Victory Capital Management Inc.

Ticker Report Victory Capital Management Inc. lifted its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 23.2% in the second quarter, Holdings Channel reports. The firm owned 1,405,553 shares...\n more…

Perrigo (PRGO) Passes Through 4% Yield Mark
Perrigo (PRGO) Passes Through 4% Yield Mark

Dividend Channel In trading on Monday, shares of Perrigo Company plc (PRGO) were yielding above the 4% mark based on its quarterly dividend (annualized to 1.104), with the stock changing hands as low as...\n more…

National Bank of Canada FI Has $8.45 Million Holdings in Perrigo Company plc (NYSE:PRGO)
National Bank of Canada FI Has $8.45 Million Holdings in Perrigo Company plc (NYSE:PRGO)

Zolmax National Bank of Canada FI trimmed its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 48.1% during the second quarter, Holdings Channel.com reports. The firm owned 322,000...\n more…

Comparing Perrigo (NYSE:PRGO) & Inhibitor Therapeutics (OTCMKTS:INTI)
Comparing Perrigo (NYSE:PRGO) & Inhibitor Therapeutics (OTCMKTS:INTI)

Ticker Report Perrigo (NYSE:PRGO - Get Free Report) and Inhibitor Therapeutics (OTCMKTS:INTI - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies...\n more…

Perrigo Company plc (NYSE:PRGO) Shares Sold by Principal Financial Group Inc.
Perrigo Company plc (NYSE:PRGO) Shares Sold by Principal Financial Group Inc.

Ticker Report Principal Financial Group Inc. decreased its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 13.6% during the 2nd quarter, according to the company in its most recent 13F filing...\n more…